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Abstract: 
To understand the reported cross-reactivity of the 2009 H1N1 and the 1918 H1N1 pandemic viruses we docked the crystal structure of 2D1, an antibody derived 
from a survivor of the 1918 pandemic, to the structures of hemaglutinin (HA) of the 2009 strain and seasonal H1 vaccine strains. Our studies revealed that 2D1 
binds to the 2009 HA at antigenic site ‘Sa’, with stabilizing contacts, similar to that in an available co-crystal structure of 2D1-1918 HA. However, 2D1 failed to 
bind to the known antigenic sites in the HAs of seasonal strains. Our study thus reveals the molecular basis for pre-existing immunity in elderly people to the 2009 
pandemic virus. 
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Background: 
The 1918 H1N1 influenza pandemic has been referred as the ‘mother’ of all 
pandemics. Studies on epidemiological features
  [1, 2], neutralization
  [3], 
hemaglutinin (HA) receptor binding and glycosylation sites
 [4] and antigenic 
epitopes
 [5] have provided evidence that the 2009 H1N1 pandemic virus is 
closer to the 1918 virus than other seasonal H1N1 Influenza viruses. Antigenic 
analysis has shown that antibodies to the seasonal H1N1 virus do not protect 
against the pandemic H1N1 virus. However, other studies [3, 6] have shown 
that a significant percentage of people aged 65 and older do have some 
immunity against the pandemic virus. This suggests that the presence of pre-
existing cross-reactive antibodies provides protection against the 2009 virus in 
people born early in the 20
th century. Xu et al. (2010) reported a co-crystal 
structure of an antibody 2D1, derived from a survivor of the 1918 pandemic, 
and the hemaglutinin of A/South Carolina/1/1918  (SC1918)  and also the 
crystal structure of  HA of  A/California/04/2009 (CA2009) [7]. Among the 
known antigenic sites in H1 HAs, namely Sa, Sb, Ca1, Ca2 and Cb [8], the 2D1 
antibody largely binds to the Sa antigenic site at the apex of the globular head 
of the HA protein and also forms contacts with residues outside this site.  The 
binding residues in SC1918 were also conserved in CA2009 except for the two 
mutations, V169I and S159N. The authors speculated that these two amino acid 
changes may not adversely affect the antibody binding. They substantiated 
their results by demonstrating that the antibody 2D1 exhibits strong binding to 
both 1918 HA and CA2009 HA, but not to HAs of seasonal influenza subtypes, 
A/Puerto Rico/8/1934 (PR1934) and A/Brisbane/59/2007 (BR2007), as tested 
in ELISA assays. However, in the absence of the crystallographic structure of 
the HA of the 2009 pandemic H1N1 virus bound with an antibody we 
attempted to determine the nature of the reactivity between the 2D1 antibody 
and CA2009 HA, PR1934 and BR2007 using in-silico docking studies. We 
compared the binding of 2D1 to the CA2009 HA and the HA of seasonal H1N1 
strains, both in terms of the specificity to the antigenic site and the total energy 
of the complex. This would provide insight into the molecular basis for the 
cross-reactivity and protection between the 2009 H1N1 and the 1918 pandemic 
viruses and not other seasonal H1N1 strains. 
 
Methodology: 
The co-crystal structure of the antibody (Fab 2D1) and the HA protein of 
A/South Carolina/1/1918 (3LZF.pdb) and the HA proteins of 
A/California/04/2009 (3LZG.pdb), A/Puerto Rico/8/1934 (1RU7.PDB) were 
obtained from the Protein Data Base (PDB). A homology model for residues 18 
to 508 of the HA of A/Brisbane/59/2007 strain was built using the template, 
chain B of A/Japan/305/1957 (H2N2), using the Swiss Model automated server 
(http://swissmodel.expasy.org). Sequence identity and similarity with template 
(2WRE.pdb) were found to be 64.97% and 79.8% respectively. Sequence 
comparisons were performed as per methods stated elsewhere 
[9].Computational docking, a method which predicts the preferred stable 
orientation of one molecule when bound to a second one, was carried out to 
determine the binding site and the residues interacting within the antigen-
antibody complex through hydrogen bonds (H-bonds) and salt bridge contacts. 
In silico antigen-antibody docking was performed by using the ZDOCK online 
server [10] using default parameters [11]. The antibody Fab 2D1 was subjected BIOINFORMATION  open access 
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to docking against the HA proteins of CA2009, BR2007 and PR1934 using 
‘blind’ (non-targeted) docking protocol. From the ten solutions returned by 
ZDOCK, the best solution was the one which satisfied the following 
conditions: i) the complimentarity determining regions (CDRs)  of the antibody 
interacting with the antigen at the antigen-antibody interface and ii) the value 
of minimized energy of the complex being the least or energetically favourable. 
For the energy minimization calculations, a GROMOS96 force-field 
application in SwissPDBViewer (SPDBV) [12] was considered. The structural 
divergence was evaluated by structural superimposition and determination of 
the root mean square deviation (RMSD) using SPDBV.
  For structure 
visualization and hydrogen bond analyses, the Accelerys’ Discovery Studio 
package (Accelerys Inc., USA) was utilized. NOC [13] was used for 
determining the electrostatic surface potential of the HA protein structures 
studied. The details of contacts between the amino acids of antigen and 
antibody for each complex were obtained by the Contacts of Structural Units 
(CSU) analyses online facility [14]. The numbering of amino acid residues in 
all the structures considered in this study is as per the HA nomenclature by 
Brownlee et al. [15]. 
 
 
Figure 1: (A) Antibody 2D1 docked in the CA2009 HA monomer. 2D1 light 
and heavy chains in cyan and blue respectively recognizes ‘Sa’ site indicated in 
pink. (B)  Interacting residues in 2D1-CA2009 HA complex, with H-bonds 
shown  in green dashes (C) Comparison of the electrostatic surface charge 
distribution in the ‘Sa’ region (circled) of the HAs of SC1918, PR1934, 
BR2007 and CA2009 viruses. Blue, white and red colors indicate basic, 
neutral, and acidic charge distribution respectively. 
 
Discussion: 
Docking of 2D1 onto the crystal structure of CA2009 HA was carried out to 
determine the binding site and the residues interacting within the antigen-
antibody complex through hydrogen bonds (H-bonds) and salt bridges. The 
2D1 antibody docked into the Sa antigenic site of CA2009 HA. However, in 
comparison with SC1918 HA-2D1 co-crystal, some changes were observed in 
the orientation of the antibody (Figure 1A). The antibody formed three H-
bonds and one salt bridge with the HA residues within the Sa site, and five 
hydrogen bonds and one salt bridge outside the Sa site in the 2D1-CA2009 HA 
complex (Table 1 see Supplementary material). When compared with the 
SC1918 HA-2D1 co-crystal, within the Sa site, the H-bonds formed by 166K 
and 167S with the 2D1 light chain and the salt bridge between 166K and 93D 
in the 2D1 light chain were retained in the CA2009 HA-2D1 complex (Figure. 
1B, Table 1 see Supplementary material). Outside the Sa site, the H-bond 
between 126S and 93D was retained. The changed orientation in CA2009 HA-
2D1 complex enabled formation of new H-bonds between 119E and 58Y in the  
heavy chain complementarity determining region 2 (HCDR2) and 95D in the 
light chain CDR3 (LCDR3) and 171D with 94S in LCDR3. Salt bridges were 
formed by 123K and 54D in HCDR2; 166K and 93D in LCDR3. The mutation 
N171D in CA2009 facilitated the new H-bond formed by 171D. On the other 
hand, when the docking of 2D1 on to the HA of BR2007 and PR1934 was 
carried out, the antibody could not recognize antigenic site Sa or other known 
antigenic sites (Figure 2). In case of BR2007 the docking program returned a 
complex wherein the antibody formed three H-bonds between 246E and 57Y of 
the 2D1 heavy chain, 170N and 32T (in 2D1 light chain) and 125S and 94S (in 
2D1 light chain). In case of PR1934, the antibody formed three H-bonds 
between 215P and G100, 212R and 54D and 201Y and 54D all in the 2D1 
heavy chain. 
 
 
Figure 2: Docking positions of 2D1 antibody with HA protein monomers from 
PR1934 and BR2007 obtained using the ZDOCK program. These positions are 
physically unrealistic orientations because under normal physiological 
conditions the interfacing residues on the antigen are embedded in the core of 
HA trimer. The HA proteins are shown in Orange color, Heavy and light chains 
are colored in Blue and Cyan respectively. 
 
 
Figure 3: Multiple alignment of Hemagglutinin protein sequences. Epitopes 
Sa, Sb, Ca1, Ca2 and Cb are highlighted in Red, Cyan, Green, Pink  and Grey 
respectively. The putative glycosylation sites are indicated in blue-lined boxes. 
The residue number 1, as referred in the text, corresponds to the residue 
number 14 in the sequence alignment (Brownlee GG, et al. Phil. Trans. R. Soc. 
Lond. B (2001), 356:1871-1876.). BIOINFORMATION  open access 
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In order to understand the above docking results, we compared the amino acids 
61 to 260, forming the head region of the HA proteins of the 1918 and 2009 
pandemic H1N1 as well as seasonal H1N1 viruses, for sequence and structural 
divergence. Between the 1918 and 2009 HAs in the head region, the amino 
acid identity was 81% while the root mean square deviation (RMSD), a 
measure of structural divergence, was estimated to be 0.92 Å over the 
backbone atoms. In CA2009, only a single mutation S159N was observed in 
the Sa site (Figure 3). However, the RMSD between the Sa sites of the two HA 
proteins was 0.64 Å. Perhaps, S159N and other mutations in the flanking 
region may account for the structural deviation. Surface charge distribution 
over the surface of HA may also affect antibody binding. The electrostatic 
surface potential in the Sa region ranged from +0.6 to +1.2 ev  in SC1918 HA 
and  from +0.68 to +1.36 eV in CA2009 HA (Figure 1C). The varied surface 
charge distribution along with the conformational deviation in the Sa site may 
be responsible for the altered orientation of 2D1 in the CA2009 HA-2D1 
complex. The minimized total energy of the SC1918 HA-2D1 co-crystal was -
38,910.35 KJ/mol while of the CA2009 HA-2D1 complex it was -38,436.36 
KJ/mol. When the Sa site residues of the SC1918 strain were compared to the 
equivalent site in BR2007 and PR1934, it was seen that there was a 38.5% 
amino acid divergence in both cases (Figure 3). The electrostatic charge 
distribution on the surface of HA of BR2007 and PR1934 in the Sa region was 
also compared (Figure 1C). It was noted that the potential varied from -0.7 to 
+1.40 eV in case of PR1934 HA and from -0.56 to +1.11 eV in case of BR2007 
HA, indicating that the Sa region in the HAs of the seasonal strains was more 
acidic with respect to that of the 1918 HA. 
 
The BR2007 HA possessed three additional glycosylation sites when compared 
to SC1918, of which two, at amino acid positions 129 and 160 fall in the ‘Sa’ 
site  (Figure 3). The presence of these two glycosylation sites at the ‘Sa’ 
epitope of BR2007 may provide protection against neutralization by the 
antibody and thus evasion of the immune system. Further, though the docking 
program generated a complex of 2D1 bound to HA of strain BR2007, such a 
complex would not be feasible under natural physiological conditions. This is 
because, some of the amino acids on the HA forming H-bonds with the 
antibody actually remained partially buried in the HA pre-fusion trimer and 
hence are inaccessible for antibodies.PR1934 HA has no additional 
glycosylation site associated with any of the antigenic sites when compared to 
SC1918. However, several of the amino acid replacements in the ‘Sa’ site of 
PR1934 (Figure 3) were non-homologous and included substitutions K156E, 
G158E, S165K and K166N which may have affected the overall charge 
distribution in the Sa region. This probably resulted in the docking of the 
antibody into a totally different region of HA. This region is again not fully 
exposed in the trimeric structure and therefore the docked complex is not 
physiologically feasible.Overall, docking studies of 2D1 onto the CA2009 HA 
revealed that the antibody 2D1 recognizes the similar region on HA of strain 
CA2009. Compared to the co-crystal of SC1918 HA – 2D1, we noted a loss of 
few contacts and a gain of a few in the CA2009 HA - 2D1 docked complex. 
Notably, the residues 126S, 166K and 167S common to the HA proteins of 
both SC1918 and CA2009 strains formed H-bonds with the antibody 2D1. The 
formation of the new H-bonds and salt bridges might have contributed to the 
stability of the CA2009 HA-2D1 complex so that the minimized total energy of 
the SC1918 HA-2D1 co-crystal was comparable to that of the CA2009 HA-
2D1 complex. On the other hand, the substantial amino acid differences and the 
resulting altered surface charge distribution in the Sa epitope region of the 
seasonal H1 HAs can explain the reason for the antibody failing to recognize 
the Sa site. 
 
Conclusion: 
Our docking studies suggest that the binding of the 1918 H1N1 antibody to the 
2009 pandemic H1N1 hemagglutinin is comparable to that with the 1918 virus, 
both in terms of the specificity to the antigenic site as well as the total energy 
of the antigen-antibody complex. The structural basis for the antibody not 
recognizing the HAs of seasonal strains could be explained. The results of the 
study therefore, reveal the molecular basis for reported cross-reactivity of the 
1918 and 2009 pandemic viruses and pre-existing immunity in elderly people. 
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Supplementary material:  
 
Table 1: Comparison of the H-bonds and salt bridge contacts between interacting residues in the docked CA2009 HA - 2D1 complex and those in the 1918SC 
HA-2D1 co-crystal. Residues within the ‘Sa’ antigenic site are indicated in bold font. Residue numbers of the heavy and light chain are prefixed with H and L 
respectively. 
HA 1918SC-2D1  CA2009 HA -2D1 
HA1 residue  2D1 residue  Type  Distance (Å)  HA1 residue  2D1 residue  Type  Distance (Å) 
125S 
126S  
129N  
157N 
157N 
160S 
160S 
161Y 
161Y 
163K 
163K 
166K 
166K 
166K 
167S 
L-91 
L-93 
H-97 
H52 
H54 
H-97 
H-99 
H-99 
H100 
H-100 
H-100 
L-31 
L-93 
L-93 
L-30 
H-bond 
H-bond 
H-bond 
Salt 
Salt 
H-bond 
H-bond 
H-bond 
H-bond 
H-bond 
Salt 
H-bond 
H-bond 
Salt 
H-bond 
3.0 
3.2 
3.2 
3.7 
3.0 
3.0 
2.5 
3.1 
3.1 
2.7 
2.7 
2.9 
2.7 
2.7 
3.1 
119E 
119E 
123K 
123 K 
126S 
166K 
166K 
166K 
167S 
171D 
H-58 
L-95 
H -54 
H -54 
L-93 
L-31 
L-93 
L-93 
L-30 
L-94 
H-bond 
H-bond 
H-bond 
Salt 
H-bond 
H-bond 
H-bond 
Salt 
H-bond 
H-bond 
3.0 
3.2 
2.2 
2.2 
3.2 
2.1 
1.9 
1.9 
3.2 
2.7 
 
 
 
 